INHIBITION OF HCV REPLICATION BY CCR5 BLOCKADE WITH CENICRIVIROC AND MARAVIROC

被引：1
|
作者：
Sherman, K. E. [1 ]
Kong, L. [1 ]
Blackard, J. T. [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Digest Dis, Cincinnati, OH USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31109-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0906
引用
收藏
页码：S684 / S684
页数：1
相关论文
共 50 条
  • [41] CCR5 blockade modulates inflammation and alloimmunity in primates
    Schroeder, Carsten
    Pierson, Richard N., III
    Nguyen, Bao-Ngoc H.
    Kawka, Douglas W.
    Peterson, Laurence B.
    Wu, Guosheng
    Zhang, Tianshu
    Springer, Martin S.
    Siciliano, Sal J.
    Iliff, Susan
    Ayala, Julia M.
    Lu, Min
    Mudgett, John S.
    Lyons, Kathy
    Mills, Sander G.
    Miller, Geraldine G.
    Singer, Irwin.
    Azimzadeh, Agnes M.
    DeMartino, Julie A.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (04): : 2289 - 2299
  • [42] Therapeutic CCR5 blockade illuminates IRIS pathogenesis
    French, Martyn A.
    LANCET HIV, 2014, 1 (02): : E50 - E51
  • [43] Overcoming hERG affinity in the discovery of maraviroc; A CCR5 antagonist for the treatment of HIV
    Price, David A.
    Armour, Duncan
    de Groot, Marcel
    Leishman, Derek
    Napier, Carolyn
    Perros, Manos
    Stammen, Blanda L.
    Wood, Anthony
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (13) : 1140 - 1151
  • [44] Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model
    Ochoa-Callejero, Laura
    Perez-Martinez, Laura
    Rubio-Mediavilla, Susana
    Oteo, Jose A.
    Martinez, Alfredo
    Blanco, Jose R.
    CANCER RESEARCH, 2012, 72
  • [45] Cenicriviroc ameliorates the severity of graft-versus-host disease through inhibition of CCR5 in a rat model of liver transplantation
    Li, Minhuan
    Lu, Chenglin
    Zhu, Hao
    Kang, Xing
    Wang, Feng
    Shao, Lihua
    Lu, Xiaofeng
    Chen, Wei
    Xia, Xuefeng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (06): : 3438 - 3449
  • [46] Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activityof Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment
    Lefebvre, E.
    Gottwald, M.
    Lasseter, K.
    Chang, W.
    Willett, M.
    Smith, P. F.
    Somasunderam, A.
    Utay, N. S.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2016, 9 (03): : 139 - 148
  • [47] CCR5 inhibition in colorectal cancer patients
    Halama, Niels
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S366 - S367
  • [48] Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
    Lefebvre, Eric
    Moyle, Graeme
    Reshef, Ran
    Richman, Lee P.
    Thompson, Melanie
    Hong, Feng
    Chou, Hsin-I
    Hashiguchi, Taishi
    Plato, Craig
    Poulin, Dominic
    Richards, Toni
    Yoneyama, Hiroyuki
    Jenkins, Helen
    Wolfgang, Grushenka
    Friedman, Scott L.
    PLOS ONE, 2016, 11 (06):
  • [49] Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist
    Princen, K
    Hatse, S
    Vermeire, K
    Aquaro, S
    De Clercq, E
    Gerlach, LO
    Rosenkilde, M
    Schwartz, TW
    Skerlj, R
    Bridger, G
    Schols, D
    JOURNAL OF VIROLOGY, 2004, 78 (23) : 12996 - 13006
  • [50] Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
    Tan, Qiuxiang
    Zhu, Ya
    Li, Jian
    Chen, Zhuxi
    Han, Gye Won
    Kufareva, Irina
    Li, Tingting
    Ma, Limin
    Fenalti, Gustavo
    Li, Jing
    Zhang, Wenru
    Xie, Xin
    Yang, Huaiyu
    Jiang, Hualiang
    Cherezov, Vadim
    Liu, Hong
    Stevens, Raymond C.
    Zhao, Qiang
    Wu, Beili
    SCIENCE, 2013, 341 (6152) : 1387 - 1390
12345